As a follow-up question, If the drug companies wont do it, why doesnt someone else run a drug trial on cesium?
Again, good question, easy answer. Today it is estimated that the cost of running a full complete series of Phase I, II and III clinical trials to obtain FDA approval for a new drug is between $600,000,000 and $800,000,000. This is clearly beyond the financial capabilities of most people and institutions. As mentioned above, no company would spend such a vast sum without the assurance of obtaining a patent to protect their investment. I would, however, like to also address the broader issue of the manner in which drug trials are currently being conducted. How often have you seen a headline touting the latest clinical trial results for a new cancer drug, claiming a cure is just around the corner? How many of these miracle cures are still being touted a year or two later? Indeed, if so many cures are being found, why are age adjusted cancer rates continuing to rise? The answer is simple: there is little substance behind the hype. Despite organized medicines insistence on placebo-controll
